Morepen Board proposed dividend after 23 years

Scores highest PAT of Rs. 118 crore in FY25

Morepen to launch new fatty lever drug ‘Resmetirom’

Morepen to add 1,000 medical representatives

The company is targeting a Rs. 1,000 crore finished dosages business within the next five years

Dr. Morepen’s diabetes awareness campaign kicks on KBC

This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets

Morepen Laboratories net profit up 189%

R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices